Propelling Genomic Research with Future-Proof Digital Infrastructure

Digital transformation in healthcare has been D at breakneck speed since the outbreak of the COVID-109.

It took just a year to develop the COVID-19 vaccine a record-breaking speed given vaccine development usually takes up to 10 years or more. This medical achievement would not have been possible without innovative technology and the advancement of genomic sequencing, allowing researchers to map the entire genetic makeup of an organism.

BCC Research has forecasted the Asia Pacific market for Bioinformatics in genomics to register a CAGR of 11 per cent from 2020 to 2025, against the rising prevalence of infectious diseases such as COVID-19. With the expanding market value of genomics amid Asia Pacific’s MedTech landscape, more R&D institutions are being established to explore novel solutions based on the study of genomes. This can largely be attributed to the increase of awareness and adaptation of genomic applications in Asia Pacific countries as well as improvements in health infrastructure, numerous urgently needed advances, increased patient disposable income and rising medical expenditures. The advancement of genomics has helped develop treatments that improve healthcare, delivering better results for patients. Earlier in 2022, Singapore and India entered into an agreement to collaborate on genome and bioinformatics research, while the Genome Institute of Singapore has embarked on mapping Asian genomes to investigate how illnesses can affect different groups, providing valuable insight for researchers. The success of genomics innovation relies on robust and agile digital infrastructure to support the entire research programme, from data processing and exchange to the ability to analyze and store increasing data volumes.